Anti-angiogenic treatment of glioblastoma with Vascular Endothelial Growth Factor (VEGF)- or VEGF Receptor 2 (VEGFR2) inhibitors normalizes tumor vessels, resulting in a serious radiologic response and improved quality of life. present with angiogenesis-dependent areas of tumor growth, as well as diffuse infiltrative growth. In cultures of E98 cells, cabozantinib effectively inhibited c-MET MAG phosphorylation, concomitant… Continue reading Anti-angiogenic treatment of glioblastoma with Vascular Endothelial Growth Factor (VEGF)- or